TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
CellScience CSAB AB
Closing information (x1000 EUR)
| Closing information | 2023/08 | 2022/08 | 2021/08 |
| Turnover |
6
|
10
|
29 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-29
|
-40
|
48 |
| EBITDA |
-68
|
-75
|
-21 |
| Total assets |
422
|
516
|
604 |
| Current assets |
186
|
228
|
310 |
| Current liabilities |
5
|
6
|
7 |
| Equity capital |
417
|
511
|
589 |
| - share capital |
8
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Solvency |
98.8%
|
99.0%
|
97.5% |
| Turnover per employee |
6
|
10
|
29 |
| Profit as a percentage of turnover |
-483.3%
|
-400%
|
165.5% |
| Return on assets (ROA) |
-6.9%
|
-7.8%
|
7.9% |
| Current ratio |
3720.0%
|
3800%
|
4428.6% |
| Return on equity (ROE) |
-7.0%
|
-7.8%
|
8.1% |
| Change turnover |
-3
|
-17
|
-24 |
| Change turnover % |
-35%
|
-62%
|
-46% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.